BPC-157 is a synthetic peptide fragment derived from a protein sequence originally identified in gastric juice, while TB-500 is modeled after Thymosin Beta-4, a naturally occurring protein involved in cellular processes
Dose: 0.51 mg per day , subcutaneous Frequency: 35 times weekly Cycle: 8 weeks on / 4 weeks off , repeated indefinitely Stack: commonly run alongside NAD+ infusions and CJC-1295 / Ipamorelin for full anti-ageing coverage
Results: At the initial stage of the study, the average quality of life score (according to SF-36) was 50.212.3 points for patients in the early stage of rehabilitation, 60.810.5 for the intermediate stage, and 70.38.9 for the late stage
Normalized were malondialdehyde (MDA)- and NO-levels in the liver, next to Western blot of NOS2 and NOS3 in the liver tissue, and decreased IL-6, TNF-, and IL-1 levels in liver tissues